View Older Stories View More Recent Stories

Apr 28, 2022 07:00AM Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors
Apr 14, 2022 05:10PM Form SC 13G STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
Apr 11, 2022 07:09AM Ginkgo Bioworks (DNA) and Elanco (ELAN) Launch BiomEdit
Apr 11, 2022 07:00AM Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
Apr 7, 2022 06:30AM Cazoo Announces Fourth Quarter and Full Year 2021 Financial Results
Apr 5, 2022 08:00AM Horizon Technology Finance Leads $15 Million Venture Loan to MyForest Foods
Apr 4, 2022 05:32PM Fluidigm (FLDM) Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
Apr 4, 2022 05:30PM Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
Apr 1, 2022 04:06PM Fluidigm (FLDM) Announces Stockholders Approve $250 Million Strategic Capital Infusion
Apr 1, 2022 04:05PM Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
Mar 29, 2022 09:30AM Fluidigm (FLDM) Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
Mar 29, 2022 09:29AM Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
Mar 28, 2022 08:33AM Fluidigm (FLDM) Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
Mar 28, 2022 08:30AM Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
Mar 25, 2022 04:00PM Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022
Mar 23, 2022 08:00AM Global Processing Services Announces New Partnership With Mastercard to Power ‘Next Generation Payments’ Technology to Global Fintechs
Mar 22, 2022 08:52PM Form 4 PROCEPT BioRobotics Corp For: Mar 18 Filed by: VIKING GLOBAL INVESTORS LP
Mar 22, 2022 05:18PM Form SC 13G/A PROCEPT BioRobotics Corp Filed by: VIKING GLOBAL INVESTORS LP
Mar 21, 2022 08:00AM Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY
Mar 17, 2022 05:58PM Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion
Mar 7, 2022 09:27AM AlphaSense Taps Industry Veteran Melissa Sargeant as Chief Marketing Officer
Mar 4, 2022 05:21PM Form SC 13D/A Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
Mar 4, 2022 07:07AM Form D/A Viking Global Equities
Mar 4, 2022 07:02AM Form D/A Viking Global Equities
Mar 4, 2022 06:57AM Form D/A Viking Global Equities
Feb 23, 2022 12:01PM FemTec Health Launches D2C Brand Awesome Woman to Bring Personalized Health and Wellness to Women in All Life Stages
Feb 22, 2022 08:00AM Independence Blue Cross and Patina announce agreement to offer Medicare Advantage members a new primary care experience
Feb 18, 2022 08:11AM FemTec Health Taps GeniusRx as Exclusive Online Pharmacy Partner for D2C Platform Awesome Woman
Feb 18, 2022 05:37AM Fluidigm (FLDM) Reports Q4 Revenue of $38.3M, Net Loss of $0.8M
Feb 17, 2022 05:43PM Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 
Feb 15, 2022 08:27AM Goldman Sachs Appoints AlphaSense as the Exclusive Distributor of its Aftermarket Research
Feb 14, 2022 06:36PM Form SC 13G/A Athira Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:34PM Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:34PM Form SC 13G/A Nuance Communications, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:25PM Form SC 13G/A 4D Molecular Therapeutic Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 06:19PM Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:38PM Form SC 13G/A PMV Pharmaceuticals, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:38PM Form SC 13G/A FIGS, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:37PM Form SC 13G/A Coupa Software Inc Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:37PM Form SC 13G/A Talaris Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:37PM Form SC 13G/A Rallybio Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A PROCEPT BioRobotics Corp Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Pharvaris N.V. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Mudrick Capital Acquisit Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Inhibrx, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Orion Acquisition Corp. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:24PM Form SC 13G/A Adaptive Biotechnologies Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:23PM Form SC 13G/A Zentalis Pharmaceuticals Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 05:23PM Form SC 13G Roivant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
Feb 14, 2022 04:24PM Form 13F-HR VIKING GLOBAL INVESTORS For: Dec 31
View More Recent Stories View Older Stories